| |
 |
|
|
Ceptaris Therapeutics Inc., a privately held, specialty
pharmaceutical company, is developing a proprietary
formulation of mechlorethamine gel for the treatment of
early stage (stages I-IIA) mycosis fungoides, a type of
Cutaneous T-Cell Lymphoma.
Based upon results of a recently completed trial,
Ceptaris
intends to file a new drug application (NDA) with the
Food and Drug Administration (FDA) in 2011. If approved,
Ceptaris' investigational drug would be the first topical mechlorethamine
product available to treat the
signs and symptoms of this rare cancer.
Ceptaris has augmented its management team with the
addition of a number of experienced pharmaceutical
executives as it approaches regulatory filing and
potential commercialization of mechlorethamine gel.
|
|
 |
|
|
|
PLEASE READ THIS AGREEMENT CAREFULLY BEFORE ACCESSING THIS
WEBSITE. BY ACCESSING THIS WEBSITE, YOU AGREE TO BE BOUND BY THE
TERMS AND CONDITIONS BELOW. IF YOU DO NOT WISH TO BE BOUND BY
THESE TERMS AND CONDITIONS, YOU MAY NOT ACCESS OR USE THIS
WEBSITE.
Ceptaris Therapeutics
is working hard to ensure that the
information provided on this website is accurate and
up-to-date., Ceptaris
does not guarantee the
accuracy or completeness of the information provided on this
website. Ceptaris reserves the right to make changes to the
content of this website from time to time without notice to you.
Permission to Browse Website and Limited Permission to Make
Copies:
You may browse this website for information and may print copies
of its contents for your own use. You must obtain the prior
written consent of Ceptaris if you want to incorporate all or some
of the contents into your own website or written materials, or
create "derivative works." . To obtain Ceptaris' written
permission, please send your written request to
info@ceptaris.com.
Remember:
Although it may be easy to copy information or websites in
cyberspace, this does not mean it is legal to do so.
Copyrights:
The information contained in the website and all copyrights to
such information are the property of Ceptaris
The owners of any copyrighted information that is the property
of third parties and which is included in the Ceptaris website
will be stated on the website. Portions of the contents of this
website are registered with the Federal Copyright Office. Please
familiarize yourself with US and International copyright laws
before using any information or contents obtained from this
website.
Links to Third Party Websites:
Please understand that when you access another website through
this website, Ceptaris
accepts no
responsibility for your experience with the third party website.
In addition, Ceptaris
does not endorse or
recommend third party websites or their contents including any
third party websites which are included by a link in this
website.
No Warranties; Limitations of Liability:
Ceptaris
assumes no responsibility for errors
or omissions on this website. ACCESS TO THIS WEBSITE IS PROVIDED
AS IS WITHOUT ANY WARRANTIES OF ANY KIND, EITHER EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF
MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR
NONINFRINGEMENT. Ceptaris
is not liable for any
special, indirect, incidental, or consequential damages,
including without limitation, lost revenues or lost profits,
which may result from the use of this website.
|
|
